What Physicians Need to Know About Advanced Therapeutic Plasma Exchange for Toxins and Inflammation — MDLifespan at AMMG 2026

MIAMI — As interest grows around the role of environmental toxins and chronic inflammation in long-term health, physicians are actively seeking new, data-informed approaches to support patients beyond traditional care models. 

At the upcoming AMMG Spring Conference 2026 (April 16–18, Trump National Doral, South Florida), MDLifespan (www.mdlifespan.com) will exhibit, sponsor, and present what healthcare providers need to know about Advanced Therapeutic Plasma Exchange (TPE)—including how it is being used within structured, physician-led protocols designed to help reduce circulating toxin burden and inflammatory mediators. 

Emerging research continues to explore how environmental exposures—such as microplastics, PFAS, and heavy metals—may contribute to chronic inflammation, metabolic dysfunction, and cognitive decline. 

While many patients prioritize lifestyle optimization, providers are increasingly recognizing that what circulates in the bloodstream may also play a critical role in overall health outcomes. 

This shift is driving demand for: 

• More advanced diagnostic insights  

• Personalized, biomarker-driven strategies  

• Clinical approaches that support the body’s ability to manage toxin burden  

Therapeutic Plasma Exchange (TPE) is a minimally invasive, well-tolerated procedure that works by filtering plasma to help remove certain circulating components, including inflammatory proteins and environmental toxins. 

MDLifespan has developed an Advanced Serial TPE approach, delivered through structured protocols, which are: 

• Physician-guided and personalized  

• Informed by diagnostic testing and biomarkers  

• Designed to support detoxification and inflammatory balance  

• Integrated with nutrient support and regenerative strategies  

This protocol-based model reflects a broader movement toward personalized, proactive health optimization. 

At AMMG, MDLifespan will highlight how its protocols are being used to support patients across key areas of health, including: 

• Cognitive and brain health  

• Cardiovascular wellness  

• Immune system balance  

• Longevity and performance optimization  

• Toxin burden and environmental exposure support  

Rather than a one-size-fits-all approach, these protocols are designed to align with individual patient goals, biomarkers, and clinical context. 

Conference attendees are invited to visit the MDLifespan exhibit to meet with the clinical team, explore how Advanced Serial TPE protocols are being implemented in practice, and learn more about: 

• Provider partnerships and referral collaboration  

• Current and upcoming treatment locations  

• Integration opportunities for physician practices  

MDLifespan’s team will be available throughout the conference to connect with physicians, healthcare professionals, and strategic partners interested in advancing personalized approaches to toxin reduction and inflammatory health. 

MDLifespan’s model is built around clinical oversight, personalization, and safety. 

Key differentiators include: 

• 100+ years of combined medical experience across the clinical team  

• Certified physicians and nurses trained in Therapeutic Plasma Exchange  

• Collaboration with the University of South Florida Morsani College of Medicine  

• Personalized tracking and data insights through the MDLifespan platform  

• Patent-pending Advanced TPE protocols focused on toxin removal and regenerative wellness  

“Healthcare is evolving toward more personalized strategies that take into account the role of toxins and inflammation in modern health challenges,” said Dr. Paul Savage, Founder and CEO of MDLifespan. “Our focus is on supporting physicians with structured, data-driven protocols that help patients address these underlying factors in a clinically guided way.” 

In addition to exhibiting, Dr. Pamela W. Smith, Chief Growth Officer and Chief Education Officer at MDLifespan, will deliver CME presentations exploring: 

• The clinical relevance of Therapeutic Plasma Exchange  

• The impact of endocrine-disrupting chemicals on health  

• The evolving role of detoxification in modern medicine  

These sessions contribute to a broader dialogue among physicians focused on prevention, longevity, and personalized care strategies. 

Healthcare professionals who are not attending AMMG can register for a complimentary live webinar on April 24, 2026, covering: 

• The science behind Advanced Serial Therapeutic Plasma Exchange  

• Clinical applications and patient selection considerations  

• Integration into practice models  

Registrants will also receive a digital copy of Avoiding Toxins: Reduce Your Toxic Exposure (2nd Edition), authored by Dr. Paul Savage and clinical contributors. 

Register at www.mdlifespan.com/provider-webinar